Fresenius Medical Care AG & Co. KGaA (FMS) Competitors $25.58 +0.32 (+1.25%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$25.60 +0.03 (+0.12%) As of 08/22/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FMS vs. ACONW, AONC, DHACW, LFMDP, OTRKP, PIIIW, TALKW, TOIIW, NTRA, and HIMSShould you be buying Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? The main competitors of Fresenius Medical Care AG & Co. KGaA include Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), Oncology Institute (TOIIW), Natera (NTRA), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry. Fresenius Medical Care AG & Co. KGaA vs. Its Competitors Aclarion American Oncology Network Digital Health Acquisition LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Natera Hims & Hers Health Aclarion (NASDAQ:ACONW) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment. Is ACONW or FMS more profitable? Fresenius Medical Care AG & Co. KGaA has a net margin of 3.39% compared to Aclarion's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.75% beat Aclarion's return on equity.Company Net Margins Return on Equity Return on Assets AclarionN/A N/A N/A Fresenius Medical Care AG & Co. KGaA 3.39%6.75%3.13% Which has stronger valuation and earnings, ACONW or FMS? Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Aclarion. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAclarion$62.95KN/AN/AN/AN/AFresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.2220.96 Do institutionals and insiders have more ownership in ACONW or FMS? 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to ACONW or FMS? In the previous week, Fresenius Medical Care AG & Co. KGaA had 4 more articles in the media than Aclarion. MarketBeat recorded 4 mentions for Fresenius Medical Care AG & Co. KGaA and 0 mentions for Aclarion. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.60 beat Aclarion's score of 0.00 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Overall Sentiment Aclarion Neutral Fresenius Medical Care AG & Co. KGaA Positive Do analysts recommend ACONW or FMS? Fresenius Medical Care AG & Co. KGaA has a consensus price target of $27.80, suggesting a potential upside of 8.70%. Given Fresenius Medical Care AG & Co. KGaA's stronger consensus rating and higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Aclarion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fresenius Medical Care AG & Co. KGaA 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryFresenius Medical Care AG & Co. KGaA beats Aclarion on 10 of the 10 factors compared between the two stocks. Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FMS vs. The Competition Export to ExcelMetricFresenius Medical Care AG & Co. KGaAMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket CapN/A$6.82B$5.75B$20.92BDividend Yield2.26%1.31%4.40%3.57%P/E Ratio20.9627.4531.2829.17Price / SalesN/A75.48433.9172.30Price / Cash5.1921.3437.7323.54Price / Book0.886.889.535.47Net Income$582.08M$176.42M$3.26B$992.74M7 Day Performance2.01%1.45%2.13%2.68%1 Month Performance-5.96%-2.71%2.81%1.53%1 Year Performance31.49%9.40%30.68%10.77% Fresenius Medical Care AG & Co. KGaA Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FMSFresenius Medical Care AG & Co. KGaA2.8344 of 5 stars$25.58+1.2%$27.80+8.7%+34.6%$0.00$20.63B20.961,384News CoverageAnalyst UpgradeShort Interest ↑ACONWAclarionN/A$0.03-0.7%N/A+49.2%$0.00$54.60K0.007Positive NewsAONCAmerican Oncology NetworkN/A$12.00+9.1%N/A+276.6%$0.00$1.34B0.001,520Gap DownDHACWDigital Health AcquisitionN/A$0.05-9.0%N/AN/A$0.00N/A0.00N/ALFMDPLifeMDN/A$24.04+1.2%N/A+9.9%$0.00$245.56M0.00230Positive NewsOTRKPOntrakN/A$0.02+2.6%N/A-90.5%$0.00$10.84M0.00250High Trading VolumePIIIWP3 Health PartnersN/A$0.01-9.1%N/A-55.9%$0.00$1.49B0.00500TALKWTalkspaceN/A$0.07-0.1%N/A+66.2%$0.00$202.61M0.00500Positive NewsTOIIWOncology InstituteN/A$0.16-13.8%N/A+704.0%$0.00$403.15M0.00660Positive NewsNTRANatera3.3977 of 5 stars$157.04+3.3%$193.87+23.5%+35.1%$21.44B$1.96B-82.224,434Positive NewsHIMSHims & Hers Health2.7894 of 5 stars$49.93-3.9%$39.83-20.2%+170.7%$11.17B$2.01B62.411,637Trending NewsAnalyst DowngradeInsider TradeGap Down Related Companies and Tools Related Companies ACONW Competitors AONC Competitors DHACW Competitors LFMDP Competitors OTRKP Competitors PIIIW Competitors TALKW Competitors TOIIW Competitors NTRA Competitors HIMS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:FMS) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care AG & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access